Lantern Pharma launches ZetaOmics cancer bioinformatics tool

Go back to Lantern Pharma launches ZetaOmics cancer bioinformatics tool
(NASDAQ: LTRN) Delayed: 1.70 -0.01 (0.58%)
Previous Close $1.71    52 Week High
Open $1.75    52 Week Low
Day High $1.75    P/E N/A 
Day Low $1.70    EPS
Volume 58,087